Transcatheter aortic valve implantation (TAVI) is a less invasive aortic valve replacement technique and is indicated for patients with symptomatic severe aortic stenosis and a high operative risk. Cerebral embolisation seems inherent to TAVI, as illustrated by the consistent appearance of new brain lesions on post-procedural MRI studies. Embolic protection devices may capture or deflect embolised material en route to the brain and thus reduce TAVI-related brain injury. Histopathology studies of captured debris revealed a diverse aetiology including recent or organised thrombotic material, tissue originating from the aortic valve, atherosclerotic plaques or myocardium and foreign body components. In this overview we provide a perspective on current evidence and implications for embolic protection devices in the dynamic TAVI field.

Additional Metadata
Keywords Aortic stenosis, Embolic protection device, Transcatheter aortic valve implantation
Persistent URL dx.doi.org/10.15420/icr.2016:30:2, hdl.handle.net/1765/100243
Journal Interventional Cardiology (London)
Rights No subscription
Citation
Kroon, H.G, & van Mieghem, N.M. (2017). Need for embolic protection during transcatheter aortic valve implantation: An interventionalist's perspective on histopathology findings. Interventional Cardiology (London), 12(1), 36–39. doi:10.15420/icr.2016:30:2